News

Researchers have found that replacing half of the blood plasma of old mice with a mixture of saline and albumin — where the albumin simply replaces protein that was lost when the original blood plasma was removed — has rejuvenating effects on the brain, liver and muscle.

Scientists have discovered an important brain-kidney cell signaling pathway which if stopped, could hold the key to treating chronic kidney disease and organ failure.

A new study has advanced the understanding of what makes pollen “penises”, called pollen tubes, grow.

A research team has used nanoparticle drug delivery to target “DADLE” – a synthetic opioid peptide – to the delta opioid receptor. This approach could provide sustained relief from chronic inflammatory pain whilst causing fewer side effects, compared to other pain-relieving medications such as opioids.

A study of our sleep during lockdown reports that for many, sleep has been longer and more regular, but of worse quality.

Inhibitory GABAergic interneurons in the hippocampus excite the developing brain at ages equivalent to the early third trimester, according to new research.

A new study has examined the egg-laying habits of nematode worms to demonstrate how a nervous system coordinates distinct behavioral outputs. That's a challenge many organisms face, albeit in different ways, during daily life.

A research has proposed a new computational system to expand the understanding of the brain at an intermediate level, between neurons and cognitive phenomena such as language. The group has developed a brain architecture that is based on neuronal assemblies, and they demonstrate its use in the syntactic processing in the production of language.

A new review of neurological symptoms of COVID-19 patients in current scientific literature reveals the disease poses a global threat to the entire nervous system, reports a new study.

A high-resolution structure of an activated dopamine receptor in its natural cell membrane environment, developed by researchers, could open up a new dimension in drug discovery for Parkinson’s disease.